| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6dccce985b8ab853026e48bca18ac56f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70 |
| filingDate |
1989-10-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_510644eec4217372cf6e208d73870d8a |
| publicationDate |
1990-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-9004399-A1 |
| titleOfInvention |
Administration of corticosteroids |
| abstract |
The effect of an 11-betahydroxy corticosteroid at the site of its desired action on a patient can be potentiated by the use of an inhibitor for the patient's 11-betahydroxy steroid dehydrogenase. The active components of liquorice, principally glycyrrhizic acid and glycyrrhetinic acid and their derivatives, have this potentiating effect if they are administered in association with the 11-betahydroxy corticosteroid, e.g. hydrocortisone, for example as a pharmaceutical composition. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-771406-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5434142-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0130383-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0130383-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02056891-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-2386373-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6548053-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0600582-A1 |
| priorityDate |
1988-10-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |